UK Health Security Agency (UKHSA) designates two new Covid-19 variants

UK Health Security Agency (UKHSA) designates two new Covid-19 variants

UK Health Security Agency (UKHSA) designates two new Covid-19 variants. Image: felipe caparros/

THE UK Health Security Agency (UKHSA) published its latest Covid-19 variant technical briefing on Friday, October 28, and designated two new strains.

The UK Health Security Agency (UKHSA) updated its analysis of Covid-19 variants currently circulating in the UK.

“A number of Omicron variants are currently circulating in England, many of which have acquired mutations which may produce a degree of immune escape,” the UKHSA said.

“Omicron sublineages BQ.1 and XBB have been given UKHSA variant designations to facilitate continued studies. Neither have currently been designated as variants of concern.”

The two variants

BQ.1 (V-22OCT-01) is a BA.5 sub-lineage which has been designated on the basis of rapid growth. So far, there have been 717 V-22OCT-01 sequences uploaded from the UK to the international GISAID database.

XBB (V-22OCT-02) is a recombinant lineage derived from 2 previous Omicron sublineages. Currently there are 18 UK samples in GISAID, out of a global total of 1,086; 639 samples have been uploaded from Singapore, and it is thought that XBB may be a factor in the recent spike in cases there.

The UKHSA added: “Neutralisation studies are currently being undertaken at the University of Oxford. Overall, data shows significant reductions in neutralisation against several of the newly emergent variants (BA.2.75.2, BA.2.3.20 and BJ.1), compared to BA.2, BA.4 and the dominant BA.5.

“This suggests that, as immunity begins to wane, these newly emerging BA.2 variants may fuel future waves of SARS-CoV-2 infection.”

Dr Meera Chand, Director of Clinical and Emerging Infection at UKHSA, said: “It is not unexpected to see new variants of SARS-CoV-2 emerge. Neither BQ.1 nor XBB have been designated as variants of concern and UKHSA is monitoring the situation closely, as always.

“Vaccination remains our best defence against future COVID-19 waves, so it is still as important as ever that people come take up all the doses for which they are eligible as soon as possible.”

Thank you for taking the time to read this article, do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories and remember, you can also follow us on Facebook and Instagram.

Written by

Matthew Roscoe

Originally from the UK, Matthew is based on the Costa Blanca and is a web reporter for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at